Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Nardo, AD; Schneeweiss-Gleixner, M; Bakail, M; Dixon, ED; Lax, SF; Trauner, M.
Pathophysiological mechanisms of liver injury in COVID-19.
Liver Int. 2021; 41(1):20-32
Doi: 10.1111/liv.14730
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Trauner Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The recent outbreak of coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has resulted in a world-wide pandemic. Disseminated lung injury with the development of acute respiratory distress syndrome (ARDS) is the main cause of mortality in COVID-19. Although liver failure does not seem to occur in the absence of pre-existing liver disease, hepatic involvement in COVID-19 may correlate with overall disease severity and serve as a prognostic factor for the development of ARDS. The spectrum of liver injury in COVID-19 may range from direct infection by SARS-CoV-2, indirect involvement by systemic inflammation, hypoxic changes, iatrogenic causes such as drugs and ventilation to exacerbation of underlying liver disease. This concise review discusses the potential pathophysiological mechanisms for SARS-CoV-2 hepatic tropism as well as acute and possibly long-term liver injury in COVID-19. © 2020 The Authors. Liver International published by John Wiley & Sons Ltd.
- Find related publications in this database (using NLM MeSH Indexing)
- Angiotensin-Converting Enzyme 2 - physiology
- COVID-19 - complications
- Cholestasis - etiology
- Humans -
- Liver - virology
- Liver Diseases - etiology
- Non-alcoholic Fatty Liver Disease - etiology
- SARS-CoV-2 -
- Viral Tropism -